StockData
Sana Biotechnology, Inc. logo

Sana Biotechnology, Inc. (SANA) stock

SANANasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 5/30
$1.85−0.03 (-1.60%)

Close on Nov 18, 2026Market cap $553.82MP/E –Yield –

Sana Biotechnology total assets

Total assets on the balance sheet at the end of each period.

Sana Biotechnology's total assets was $431.52M at Jun 30, 2026. For fiscal 2025 it was $416.89M, down 16.8% from the year before. The highest annual figure on record is $1.13B in fiscal 2021.

Annual total assets

PeriodPeriod endValueChange
FY2025Dec 31, 2025$416.89M-16.8%
FY2024Dec 31, 2024$501.02M-11.4%
FY2023Dec 31, 2023$565.30M-31.3%
FY2022Dec 31, 2022$822.72M-27.2%
FY2021Dec 31, 2021$1.13B+54.7%
FY2020Dec 31, 2020$730.30M–

Quarterly total assets

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$431.52M+19.3%
Q1 FY2026Mar 31, 2026$373.59M-16.1%
Q4 FY2025Dec 31, 2025$416.89M-16.8%
Q3 FY2025Sep 30, 2025$435.43M-22.2%
Q2 FY2025Jun 30, 2025$361.65M-41.5%
Q1 FY2025Mar 31, 2025$445.47M-34.6%
Q4 FY2024Dec 31, 2024$501.02M-11.4%
Q3 FY2024Sep 30, 2024$559.39M-11.4%
Q2 FY2024Jun 30, 2024$618.67M-12.5%
Q1 FY2024Mar 31, 2024$681.38M-8.8%
Q4 FY2023Dec 31, 2023$565.30M-31.3%
Q3 FY2023Sep 30, 2023$631.44M-29.7%
Q2 FY2023Jun 30, 2023$707.15M-27.2%
Q1 FY2023Mar 31, 2023$746.93M-28.7%
Q4 FY2022Dec 31, 2022$822.72M-27.2%
Q3 FY2022Sep 30, 2022$898.10M-27.1%
Q2 FY2022Jun 30, 2022$971.09M-22.9%
Q1 FY2022Mar 31, 2022$1.05B-19.7%
Q4 FY2021Dec 31, 2021$1.13B+54.7%
Q3 FY2021Sep 30, 2021$1.23B–
Q2 FY2021Jun 30, 2021$1.26B–
Q1 FY2021Mar 31, 2021$1.30B–
Q4 FY2020Dec 31, 2020$730.30M–

More Sana Biotechnology figures

See a number that looks wrong?